Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Logan

Showing results (491-500 of 516) with videos related to

Pageof 52
Sort By:
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Blood Advances|February 25, 2020
Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yieldNosha Farhadfar, Jack W Hsu, Brent R Logan, et al.
The Lancet. Haematology|March 3, 2019
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)Javier Bolaños-Meade, Ran Reshef, Raphael Fraser, et al.
Blood Advances|July 1, 2025
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemiaMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Bone Marrow Transplantation|June 10, 2020
Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysisNosha Farhadfar, Hemant S Murthy, Brent R Logan, et al.
Bone Marrow Transplantation|May 2, 2020
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysisNosha Farhadfar, Hemant S Murthy, Brent R Logan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Journal of Human Immunity|January 29, 2026
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC studyVirdette L Brumm, Sharon A Kidd, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2019
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over TimeNicole L Prokopishyn, Brent R Logan, Deidre M Kiefer, et al.
The New England Journal of Medicine|July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
Pageof 52

Showing results (491-500 of 516) with videos related to

Sort By:
Pageof 52
Blood|October 13, 2017
Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history studyJennifer Heimall, Brent R Logan, Morton J Cowan, et al.
Blood Advances|February 25, 2020
Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yieldNosha Farhadfar, Jack W Hsu, Brent R Logan, et al.
The Lancet. Haematology|March 3, 2019
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)Javier Bolaños-Meade, Ran Reshef, Raphael Fraser, et al.
Blood Advances|July 1, 2025
Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemiaMark J Levis, Mehdi Hamadani, Brent R Logan, et al.
Bone Marrow Transplantation|June 10, 2020
Correction: Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysisNosha Farhadfar, Hemant S Murthy, Brent R Logan, et al.
Bone Marrow Transplantation|May 2, 2020
Impact of autologous blood transfusion after bone marrow harvest on unrelated donor's health and outcome: a CIBMTR analysisNosha Farhadfar, Hemant S Murthy, Brent R Logan, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Journal of Human Immunity|January 29, 2026
Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC studyVirdette L Brumm, Sharon A Kidd, Brent R Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2019
The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over TimeNicole L Prokopishyn, Brent R Logan, Deidre M Kiefer, et al.
The New England Journal of Medicine|July 31, 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009Sung-Yun Pai, Brent R Logan, Linda M Griffith, et al.
Pageof 52